Results 121 to 130 of about 47,203 (289)
Beyond abstinence: Redefining success in cannabis use disorder treatment
Addiction, EarlyView.Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin +3 more
wiley +1 more source
Cannabinoids in Gynecological Diseases
, 2019 The endocannabinoid system (ECS) is a multifunctional homeostatic system involved in many physiological and pathological conditions. The ligands of the ECS are the endocannabinoids, whose actions are mimicked by exogenous cannabinoids, such as ...
Petra Luschnig, Rudolf Schicho
core +1 more source
Addiction, EarlyView.Abstract Background and Aims The introduction of prescribed medical cannabis in many parts of the world raises issues regarding how we conceptualise Cannabis Use Disorders (CUD). The Diagnostic Statistical Manual Version 5 (DSM5) provides a framework for ‘Prescription Cannabis Use Disorder’ (Pr‐CUD) when a person is using medical cannabis only‐as ...
Nicholas Lintzeris, Llewellyn Mills
wiley +1 more source
Addiction, EarlyView.Abstract Background and aims Use of derived intoxicating cannabinoid products (DICPs) has grown in the United States (US), as have associated poisonings, emergency department visits and psychotic episodes. Brand marketing on social media, a largely underregulated marketing channel, may be contributing to this growth.
Kathryn La Capria +10 more
wiley +1 more source
, 2020 Provided are synthesis processes and intermediates for preparing cannabinoids and ...
Leahy, James William +2 more
core
Addiction, EarlyView.Abstract Background and aims Over the past decade, there has been increased lifetime use of illicit and medical cannabis, underscoring the need to examine public health impacts. This includes reports of increased cannabis‐related psychosis. In this context, this study aimed to determine all cannabis‐related hospital admissions in Victoria, Australia ...
Myfanwy Graham +5 more
wiley +1 more source
Addiction, EarlyView.Abstract Background and aims Cannabis edible products are increasingly being sold on the illicit market around the world. Use of these products, typically labelled as containing Δ‐9‐tetrahydrocannabinol (THC), has been linked to adverse health effects, particularly amongst adolescents.
Matthew Gardner +9 more
wiley +1 more source
Addiction, EarlyView.Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke +5 more
wiley +1 more source
Addiction, EarlyView.Abstract Background and aims While evidence on the individual effects of prenatal cannabis and tobacco exposure on offspring cognition is accumulating, their combined impact remains understudied. Therefore, we examined the interaction between prenatal cannabis and tobacco exposure on fluid (e.g. reasoning abilities) and crystallized (e.g.
Mathilde Argote +2 more
wiley +1 more source
Synthetic cannabinoids: Analytical methods
, 2015 Considering the growing interest in synthetic cannabinoids, we propose to review the main analytical methods allowing their detection and/or quantification in biological samples (blood, urine, oral fluid and hair) and products (powders, herbal mixtures).
Mazoyer C. +3 more
core +1 more source